3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
22
Breast Neoplasms
21
Neoplasms
10
Brain Neoplasms
10
Glioma
8
Head and Neck Neoplasms
7
Lymphoma
6
Colonic Neoplasms
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Lymphoma, Non-Hodgkin
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Glioblastoma
4
Carcinoma, Hepatocellular
4
Astrocytoma
4
Squamous Cell Carcinoma of Head and Neck
3
Spinal Cord Neoplasms
3
Lung Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Meningioma
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Interventions
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Blood Specimen Collection
6
Prednisone
5
Positron Emission Tomography Computed Tomography
4
Mammography
4
Lenalidomide
4
Colonoscopy
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surveys and Questionnaires
3
Melphalan
3
Exercise
3
Biopsy
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Methods
2
Magnetic Resonance Imaging
2
Injections
2
Gemcitabine
2
Educational Status
2
Doxorubicin
2
Cytarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Disease
×
Magnetic Resonance Imaging
×
Clear all
NCT06629896
2026-05-07
CEM
Azienda USL Reggio Emilia - IRCCS
Phase NA
Recruiting
2,200 enrolled
NCT04803188
2021-03-17
ProSa-I
University of Roma La Sapienza
Phase NA
Unknown
710 enrolled